With increasing information overload and packed work schedules, staying up-to-date on the newest oncologic advances is harder than ever. But take heart! The QuadShot is freshly brewed in your inbox four mornings each week so you can quickly down and digest the day's most pertinent cancer news.
The idea has far outlived initial stock portfolios. This thought-experiment provides an economic framework for how to assess the cost-effectiveness of future explorations into serum biomarkers for more targeted lung cancer screening algorithms. | Larose, JAMA Netw Open 2020